# GLOW Peptide References: Cited Literature on GHK-Cu, BPC-157, and TB-500

> Full citation list for all GLOW peptide research covered on this site — PubMed links, DOIs, and journal references for GHK-Cu, BPC-157, and TB-500 studies.

## Primary Studies and Reviews

All citations are drawn from peer-reviewed journals, PubMed-indexed sources, or ClinicalTrials.gov. The GLOW blend as a combined formulation has no published controlled trial. All constituent-level citations are indexed below.

## Citations

[1] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. DOI: 10.1155/2015/648108 PMID: 26236730 https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
[2] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. DOI: 10.1155/2015/648108 PMID: 26236730 https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
[3] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. DOI: 10.3390/ijms19071987 PMID: 29986520 https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
[4] Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z. Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters. Journal of Aging Science. 2016;4(1):166. https://www.walshmedicalmedia.com/open-access/effects-of-ghkcu-on-mmp-and-timp-expression-collagen-and-elastin-production-and-facial-wrinkle-parameters-2329-8847-1000166.pdf
[5] Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. BioImpacts. 2024;14(6). DOI: 10.34172/bi.30071 PMID: 39963574 https://pmc.ncbi.nlm.nih.gov/articles/PMC11830136/
[6] Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. 2022. PMID 35936787. PMID: 35936787 https://pmc.ncbi.nlm.nih.gov/articles/PMC9354777/
[7] Pickart L, Vasquez-Soltero JM, Margolina A. The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health. Oxidative Medicine and Cellular Longevity. 2012;2012:324832. DOI: 10.1155/2012/324832 PMID: 22666519 https://pmc.ncbi.nlm.nih.gov/articles/PMC3359723/
[8] Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988. DOI: 10.1163/156856208784909435 PMID: 18644225 https://pubmed.ncbi.nlm.nih.gov/18644225/
[9] Lee WJ, Sim HB, Jang YH, Lee SJ, Kim DW, Yim SH. Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth. Annals of Dermatology. 2016;28(4):438-443. DOI: 10.5021/ad.2016.28.4.438 PMID: 27489425 https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/
[10] Ogorek K, Nowak K, Wadych E, Ruzik L, Timerbaev AR, Matczuk M. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? Molecules. 2025;30(1):136. DOI: 10.3390/molecules30010136 PMID: 39795193 https://pmc.ncbi.nlm.nih.gov/articles/PMC11721469/
[11] Mikus D, Sikiric P, Seiwerth S, et al. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice. Burns. 2001;27(8):817-827. DOI: 10.1016/s0305-4179(01)00055-9 PMID: 11718984 https://pubmed.ncbi.nlm.nih.gov/11718984/
[12] Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine. 2017;95(3):323-333. DOI: 10.1007/s00109-016-1488-y PMID: 27847966 https://pubmed.ncbi.nlm.nih.gov/27847966/
[13] Seiwerth S, Milavic M, Vukojevic J, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology. 2021;12:627533. DOI: 10.3389/fphar.2021.627533 PMID: 34267654 https://pmc.ncbi.nlm.nih.gov/articles/PMC8275860/
[14] Chang CH, Tsai WC, Hsu YH, Pang JHS. Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts. Molecules. 2014;19(11):19066-19077. DOI: 10.3390/molecules191119066 PMID: 25415472 https://pmc.ncbi.nlm.nih.gov/articles/PMC6271067/
[15] Vukojevic J, Milavic M, Perovic D, et al. Pentadecapeptide BPC 157 and the central nervous system. Neural Regeneration Research. 2021;17(3):631-635. DOI: 10.4103/1673-5374.320969 PMID: 34380875 https://pmc.ncbi.nlm.nih.gov/articles/PMC8504390/
[16] He L, Feng D, Guo H, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Frontiers in Pharmacology. 2022;13:1026182. DOI: 10.3389/fphar.2022.1026182 PMID: 36588717 https://pmc.ncbi.nlm.nih.gov/articles/PMC9794587/
[17] Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology. 1999;113(3):364-368. DOI: 10.1046/j.1523-1747.1999.00708.x PMID: 10469335 https://pubmed.ncbi.nlm.nih.gov/10469335/
[18] Qiu P, Kurpakus Wheater M, Qiu Y, Sosne G. Thymosin beta4 inhibits TNF-alpha-induced NF-kB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. The FASEB Journal. 2011;25(6):1815-1826. DOI: 10.1096/fj.10-167940 PMID: 21343177 https://pmc.ncbi.nlm.nih.gov/articles/PMC3101037/
[19] Dai B, Sha RN, Yuan JL, Liu DJ. Multiple potential roles of thymosin beta4 in the growth and development of hair follicles. Journal of Cellular and Molecular Medicine. 2021;25(2):1052-1060. DOI: 10.1111/jcmm.16241 PMID: 33393222 https://pmc.ncbi.nlm.nih.gov/articles/PMC7875905/
[20] Kleinman HK, Sosne G. Thymosin beta4 Promotes Dermal Healing. Vitamins and Hormones. 2016;102:251-275. DOI: 10.1016/bs.vh.2016.04.005 PMID: 27450738 https://pubmed.ncbi.nlm.nih.gov/27450738/
[21] Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005;11(9):421-429. DOI: 10.1016/j.molmed.2005.07.004 PMID: 16099219 https://pubmed.ncbi.nlm.nih.gov/16099219/
[22] McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Current Reviews in Musculoskeletal Medicine. 2025. DOI: 10.1007/s12178-025-09990-7 PMID: 40789979 https://pmc.ncbi.nlm.nih.gov/articles/PMC12446177/
[23] Mayfield CK, Bolia IK, Feingold CL, et al. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. American Journal of Sports Medicine. 2026. DOI: 10.1177/03635465251357593 PMID: 41476424 https://pubmed.ncbi.nlm.nih.gov/41476424/
[24] Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988. DOI: 10.1163/156856208784909435 PMID: 18644225 https://pubmed.ncbi.nlm.nih.gov/18644225/
[25] Yuan C, Demers A, Silva-Ortiz V, et al. From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. International Journal of Molecular Sciences. 2026;27(6):2876. DOI: 10.3390/ijms27062876 PMID: 41898733 https://pubmed.ncbi.nlm.nih.gov/41898733/

---

An archival digest of the published constituent literature on the GLOW peptide blend — not a clinic, not a vendor, not a prescription.